Illinois Municipal Retirement Fund Has $24.49 Million Holdings in Colgate-Palmolive Company $CL

Illinois Municipal Retirement Fund lifted its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 24.7% during the 3rd quarter, Holdings Channel reports. The firm owned 306,297 shares of the company’s stock after purchasing an additional 60,706 shares during the period. Illinois Municipal Retirement Fund’s holdings in Colgate-Palmolive were worth $24,485,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also made changes to their positions in CL. Brighton Jones LLC raised its holdings in Colgate-Palmolive by 4.4% in the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock valued at $962,000 after acquiring an additional 450 shares in the last quarter. Woodline Partners LP raised its holdings in shares of Colgate-Palmolive by 76.3% during the 1st quarter. Woodline Partners LP now owns 46,361 shares of the company’s stock worth $4,344,000 after buying an additional 20,062 shares in the last quarter. Concurrent Investment Advisors LLC grew its position in Colgate-Palmolive by 10.9% in the second quarter. Concurrent Investment Advisors LLC now owns 24,857 shares of the company’s stock valued at $2,259,000 after acquiring an additional 2,449 shares during the last quarter. MGO One Seven LLC grew its holdings in shares of Colgate-Palmolive by 107.2% during the 2nd quarter. MGO One Seven LLC now owns 14,351 shares of the company’s stock valued at $1,304,000 after purchasing an additional 7,424 shares during the last quarter. Finally, Sequoia Financial Advisors LLC increased its holdings in shares of Colgate-Palmolive by 18.6% during the second quarter. Sequoia Financial Advisors LLC now owns 30,273 shares of the company’s stock worth $2,752,000 after buying an additional 4,738 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Trading Up 1.5%

Shares of Colgate-Palmolive stock opened at $95.36 on Thursday. The stock’s 50-day simple moving average is $83.06 and its 200 day simple moving average is $81.73. The stock has a market capitalization of $76.87 billion, a P/E ratio of 36.40, a P/E/G ratio of 4.24 and a beta of 0.29. Colgate-Palmolive Company has a 52-week low of $74.54 and a 52-week high of $100.18. The company has a debt-to-equity ratio of 5.90, a quick ratio of 0.27 and a current ratio of 0.42.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.91 by $0.04. The company had revenue of $5.23 billion for the quarter, compared to analyst estimates of $5.13 billion. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The firm’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same period in the previous year, the company posted $0.91 EPS. As a group, research analysts anticipate that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Wednesday, January 21st will be paid a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date of this dividend is Wednesday, January 21st. Colgate-Palmolive’s payout ratio is currently 79.39%.

Insiders Place Their Bets

In other news, CFO Stanley J. Sutula III sold 97,843 shares of Colgate-Palmolive stock in a transaction dated Wednesday, February 4th. The stock was sold at an average price of $94.27, for a total value of $9,223,659.61. Following the transaction, the chief financial officer owned 55,310 shares in the company, valued at approximately $5,214,073.70. The trade was a 63.89% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Sally Massey sold 15,851 shares of Colgate-Palmolive stock in a transaction that occurred on Thursday, February 5th. The stock was sold at an average price of $95.03, for a total value of $1,506,320.53. Following the completion of the transaction, the insider directly owned 13,751 shares in the company, valued at $1,306,757.53. This trade represents a 53.55% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.34% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the stock. The Goldman Sachs Group reiterated a “buy” rating and set a $94.00 target price on shares of Colgate-Palmolive in a research report on Saturday, January 31st. Jefferies Financial Group boosted their target price on shares of Colgate-Palmolive from $85.00 to $91.00 and gave the company a “hold” rating in a report on Monday, February 2nd. Royal Bank Of Canada upgraded Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 price target on the stock in a report on Tuesday, December 9th. Bank of America upped their price objective on shares of Colgate-Palmolive from $90.00 to $100.00 and gave the company a “buy” rating in a report on Monday, February 2nd. Finally, Evercore raised their price objective on Colgate-Palmolive from $94.00 to $100.00 and gave the company an “outperform” rating in a research note on Monday, February 2nd. Eleven investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to MarketBeat.com, Colgate-Palmolive has an average rating of “Moderate Buy” and an average target price of $94.47.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.